These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 22790253)

  • 21. Regional gray matter volume abnormalities in the at risk mental state.
    Borgwardt SJ; Riecher-Rössler A; Dazzan P; Chitnis X; Aston J; Drewe M; Gschwandtner U; Haller S; Pflüger M; Rechsteiner E; D'Souza M; Stieglitz RD; Radü EW; McGuire PK
    Biol Psychiatry; 2007 May; 61(10):1148-56. PubMed ID: 17098213
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impulsivity-related brain volume deficits in schizophrenia-addiction comorbidity.
    Schiffer B; Müller BW; Scherbaum N; Forsting M; Wiltfang J; Leygraf N; Gizewski ER
    Brain; 2010 Oct; 133(10):3093-103. PubMed ID: 20647266
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural brain abnormalities in first-episode psychosis: differences between affective psychoses and schizophrenia and relationship to clinical outcome.
    de Castro-Manglano P; Mechelli A; Soutullo C; Landecho I; Gimenez-Amaya JM; Ortuño F; McGuire P
    Bipolar Disord; 2011; 13(5-6):545-55. PubMed ID: 22017223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Voxel-based morphometry of comorbid schizophrenia and learning disability: analyses in normalized and native spaces using parametric and nonparametric statistical methods.
    Moorhead TW; Job DE; Whalley HC; Sanderson TL; Johnstone EC; Lawrie SM
    Neuroimage; 2004 May; 22(1):188-202. PubMed ID: 15110009
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Voxel-based morphometry reveals gray matter abnormalities in migraine.
    Valfrè W; Rainero I; Bergui M; Pinessi L
    Headache; 2008 Jan; 48(1):109-17. PubMed ID: 18184293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Voxel-based morphometry in schizophrenia: implications for neurodevelopmental connectivity models, cognition and affect.
    Williams LM
    Expert Rev Neurother; 2008 Jul; 8(7):1049-65. PubMed ID: 18590476
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased grey matter densities in schizophrenia patients with negative symptoms after treatment with quetiapine: a voxel-based morphometry study.
    Stip E; Mancini-Marïe A; Letourneau G; Fahim C; Mensour B; Crivello F; Dollfus S
    Int Clin Psychopharmacol; 2009 Jan; 24(1):34-41. PubMed ID: 19077676
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A meta-analysis of fMRI studies in healthy relatives of patients with schizophrenia.
    Scognamiglio C; Houenou J
    Aust N Z J Psychiatry; 2014 Oct; 48(10):907-16. PubMed ID: 24972603
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between the brain-derived neurotrophic factor Val66Met polymorphism and brain morphology in a Japanese sample of schizophrenia and healthy comparisons.
    Takahashi T; Suzuki M; Tsunoda M; Kawamura Y; Takahashi N; Tsuneki H; Kawasaki Y; Zhou SY; Kobayashi S; Sasaoka T; Seto H; Kurachi M; Ozaki N
    Neurosci Lett; 2008 Apr; 435(1):34-9. PubMed ID: 18325670
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Localized volume reduction in prefrontal, temporolimbic, and paralimbic regions in schizophrenia: an MRI parcellation study.
    Yamasue H; Iwanami A; Hirayasu Y; Yamada H; Abe O; Kuroki N; Fukuda R; Tsujii K; Aoki S; Ohtomo K; Kato N; Kasai K
    Psychiatry Res; 2004 Sep; 131(3):195-207. PubMed ID: 15465289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cognitive performance and grey matter density in psychosis: functional relevance of a structural endophenotype.
    Habets P; Krabbendam L; Hofman P; Suckling J; Oderwald F; Bullmore E; Woodruff P; Van Os J; Marcelis M
    Neuropsychobiology; 2008; 58(3-4):128-37. PubMed ID: 19088490
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Voxel-based morphometry comparison between first episodes of psychosis with and without evolution to schizophrenia.
    Molina V; Sanz J; Villa R; Pérez J; González D; Sarramea F; Ballesteros A; Galindo G; Hernández JA
    Psychiatry Res; 2010 Mar; 181(3):204-10. PubMed ID: 20153145
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurological soft signs and brain morphology in first-episode schizophrenia.
    Thomann PA; Wüstenberg T; Santos VD; Bachmann S; Essig M; Schröder J
    Psychol Med; 2009 Mar; 39(3):371-9. PubMed ID: 18578894
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Brain structural changes associated with chronicity and antipsychotic treatment in schizophrenia.
    Tomelleri L; Jogia J; Perlini C; Bellani M; Ferro A; Rambaldelli G; Tansella M; Frangou S; Brambilla P;
    Eur Neuropsychopharmacol; 2009 Dec; 19(12):835-40. PubMed ID: 19717283
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals.
    Velakoulis D; Wood SJ; Wong MT; McGorry PD; Yung A; Phillips L; Smith D; Brewer W; Proffitt T; Desmond P; Pantelis C
    Arch Gen Psychiatry; 2006 Feb; 63(2):139-49. PubMed ID: 16461856
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Voxel-based morphometry of patients with schizophrenia or bipolar disorder and their unaffected relatives.
    McIntosh AM; Job DE; Moorhead TW; Harrison LK; Forrester K; Lawrie SM; Johnstone EC
    Biol Psychiatry; 2004 Oct; 56(8):544-52. PubMed ID: 15476683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Volume reduction of the left planum temporale gray matter associated with long duration of untreated psychosis in schizophrenia: a preliminary report.
    Takahashi T; Suzuki M; Tanino R; Zhou SY; Hagino H; Niu L; Kawasaki Y; Seto H; Kurachi M
    Psychiatry Res; 2007 Apr; 154(3):209-19. PubMed ID: 17321114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Brain volume and dysexecutive behavior in schizophrenia.
    Kawada R; Yoshizumi M; Hirao K; Fujiwara H; Miyata J; Shimizu M; Namiki C; Sawamoto N; Fukuyama H; Hayashi T; Murai T
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1255-60. PubMed ID: 19625009
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Meta-analysis of gray matter anomalies in schizophrenia: application of anatomic likelihood estimation and network analysis.
    Glahn DC; Laird AR; Ellison-Wright I; Thelen SM; Robinson JL; Lancaster JL; Bullmore E; Fox PT
    Biol Psychiatry; 2008 Nov; 64(9):774-81. PubMed ID: 18486104
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between structural and functional brain alterations in drug-free patients with schizophrenia: a multimodal meta-analysis.
    Gao X; Zhang W; Yao L; Xiao Y; Liu L; Liu J; Li S; Tao B; Shah C; Gong Q; Sweeney JA; Lui S
    J Psychiatry Neurosci; 2018 Mar; 43(2):131-142. PubMed ID: 29481320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.